Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy is a research paper published in Arthritis & Rheumatology (2023). On theSindex it has a DataRank of 0.770. It has been cited 28 times, with 25 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0.265
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 25 citers.
The National Institute of Environmental Health Sciences
Grant: ES1010081
The National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR‐041215‐02
Intramural NIH HHS
Grant: ZIA ES101081
Intramural NIH HHS
Grant: ZIA ES101074
Intramural NIH HHS
Grant: ZIA AR041215
BMSF
Cure JM Foundation
George Washington University
FWCI
4.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals